$ZTS

AI Analysis

Generated on May 11, 2026

AI Score
74/ 100
Hold$ZTS

Zoetis Inc.

$ZTSNYSEHealthcareLarge-Cap

Zoetis discovers, develops, and markets veterinary medicines and vaccines for livestock and companion animals.

Market Cap
$80.0B
Revenue (TTM)
$8.9B
+7.0%
Net Income (TTM)
$2.5B
+10.0%
EPS (TTM)
$5.50
P/E Ratio
32.0
Dividend Yield
0.8%
52-Week Range
$150-$205
Beta
0.72
Dimension Scores
Fundamental
76
Technical
68
Sentiment
72
Risk / Reward
74
Momentum
66
FundTechSentRiskMome
Financial Health
Profitability
81strong
Growth
69moderate
Liquidity
82strong
Solvency
78strong
Efficiency
74strong

Valuation, technical analysis, investment thesis, risk assessment and more for $ZTS

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.